当前位置:首页 » 上海招聘 » 上海复星医药(集团)股份有限公司校园招聘 » 财务部实习生

财务部实习生(上海总部,财务部)

专业标签:

【岗位职责】

1. 协助财务团队的财务预算及会计报表整合等常规工作;

2. 配合企业管理系统中涉及财务模块的操作和维护;

3. 协助团队行政工作,包括重大会议联络协调、重要访谈的接待安排等;

4. 协助财务部其他相关工作;

【任职要求】

1. 本科或硕士学历;

2. 会计学相关专业优先;

3. 通过CPA/ACCA等资格考试或通过多门者优先;

4. 有会计事务所或企业财务部实习经验者优先;

职位名称 所属机构 工作地点 职位类型 发布日期
董秘办管理培训生 上海总部 上海 全职 9月07日
品牌与公众传播部实习生(美工方向) 上海总部 上海 兼职/实习 9月07日
财务共享中心管理培训生 上海总部 上海 全职 9月07日

上海复星医药(集团)股份有限公司
上海复星医药(集团)股份有限公司(简称“复星医药”,股票代码:600196.SH,02196.HK)成立于1994年,是中国领先的医疗健康产业集团。复星医药集团业务覆盖医药健康全产业链,包括药品制造与研发、医疗服务、医疗器械与医学诊断、医药分销与零售。其中,以药品制造与研发为核心,并以医疗服务为发展重点。
复星医药集团将创新研发作为企业发展最核心的驱动因素,在中国、美国、印度等地布局,打造了高效的化学创新药平台、生物药平台、高价值仿制药平台及细胞免疫平台。目前,复星医药集团的研发持续专注于抗肿瘤、心血管系统、中枢神经系统、血液系统、代谢及消化系统、抗感染等治疗领域,且主要产品均在各自细分市场占据领先地位。
在医疗服务领域,复星医药集团已初步形成沿海发达城市高端医疗、二三线城市专科和综合医院相结合的业务战略布局。截止2018年底,复星医药集团控股的禅城医院、恒生医院、钟吾医院、温州老年病医院、广济医院、济民医院、珠海禅诚医院及武汉济和医院等核定床位合计 4,118 张;联营医院和睦家继续保持在北京、天津、上海等核心城市高端医疗领域的品牌号召力和领先地位。
面向未来,复星医药将秉承“持续创新﹒乐享健康”的品牌理念,围绕未被满足的医疗需求,坚持“4 IN”(创新Innovation、国际化Internationalization、整合Integration、智能化Intelligentization)战略和“内生式增长、外延式扩张、整合式发展”的发展模式,致力于成为全球主流医疗健康市场的一流企业。

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Established in 1994, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma”; stock code: 600196.SH, 02196.HK) is a leading healthcare group in the PRC. Fosun Pharma’s business covers all key sectors of healthcare industry chain, including pharmaceutical manufacturing and R&D, healthcare services, medical devices and medical diagnosis, as well as pharmaceutical distribution and retail, with pharmaceutical manufacturing and R&D as the core, and healthcare services as the development focus.
Fosun Pharma regards innovation, research and development as the core driving factor of development and has developed international R&D team in China, the United States., India and etc., and established innovative chemical drugs platform, biologics platform, high-value generic drugs platform and cell-therapy platform. Currently, Fosun Pharma continues to focus on therapeutic areas including oncology, cardiovascular system, central nervous system, blood system, metabolism and alimentary system and anti-infection. All major products occupy the leading position and maintained fast growth in each market segment.
In healthcare service segment, Fosun Pharma Group has strategically layout high-end medical in developed coastal cities, specialized and general hospital in second and third-tier cities. In 2018, the combined number of authorized beds controlled by Fosun Pharma including Chancheng Hospital, Hengsheng Hospital, Zhongwu Hospital, Wenzhou Geriatrics Hospital, Guangji Hospital, Jimin Cancer Hospital, Zhuhai Chancheng and Wuhan Jihe Hospital, etc. was 4,118 in aggregate. United family hospital, the affiliated hospital of Fosun Pharma Group, continues to maintain its leading position in premium healthcare in Beijing, Tianjin, Shanghai and other metropolitan in China.
Looking forward, Fosun Pharma will adhere to the brand philosophy of “Innovation for Good Health”. Focusing on the unmet medical needs, it will stick to the development model of “organic growth, external expansion and integrated development” under the guidance of “4IN” strategy (Innovation, Internationalization, Integration, Intelligentization), striving to become a first-tier enterprise in the global mainstream pharmaceutical and healthcare market.

关于我们 | 合作伙伴 | 出版物 | 触屏版 | 友情链接 | 联系我们 | 违法和不良信息举报 | 帮助指南

网站备案/许可证号:沪ICP备12015550号-13|上海市公安局徐汇分局网监中心备案编号:3101040220

上海市反电信网络诈骗中心防范劝阻电话和短信统一专号:962110,网民接到962110电话,请立即接听。

Copyright ©前锦网络信息技术(上海)有限公司版权所有